Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
Clinical trial NCT02580279 · UNKNOWN
Trial details
- NCT number
- NCT02580279
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2019-08-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.